Saturday - July 11, 2026

Category Archives: Science

Non Muscle Invasive Bladder Cancer Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Non Muscle Invasive Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, … Continue reading →

Ischemic Stroke Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Ischemic Stroke Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Ischemic Stroke pipeline landscape. It covers the Ischemic Stroke pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Huntington Disease Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Huntington’s Disease Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Huntington’s Disease pipeline landscape. It covers the Huntington’s Disease Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Wet AMD Pipeline Gains Momentum: 60+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Wet-AMD Pipeline Insight 2026” report provides comprehensive insights about 60+ companies and 75+ pipeline drugs in the Wet-AMD pipeline landscape. It covers the Wet-AMD Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet-AMD Pipeline … Continue reading →

Diabetic Macular Edema Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Wearable Medical Devices Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight

The latest market forecast report provides an in-depth analysis of the Wearable Medical Devices Market, offering comprehensive insights into the market revenue trends, segmentation, and technology landscape. The report delves into key Wearable Medical Devices Market statistics, highlighting the current … Continue reading →

Guillain-Barré Syndrome Market is Projected to Witness Significant Growth by 2036 Owing to Advancements in Targeted Immunotherapies and Emerging Disease-Modifying Treatments | DelveInsight

The Guillain-Barré Syndrome Market is anticipated to witness substantial growth during the forecast period, driven by the growing awareness and early diagnosis, advancements in supportive care, and the development of targeted immunotherapies. The emergence of promising therapies such as Tanruprubart, … Continue reading →

Type 1 Diabetes Market is Projected to Witness Significant Growth by 2034 Owing to Advancements in Cell Therapies and Emerging Disease-Modifying Treatments | DelveInsight

The Type 1 Diabetes Market is anticipated to witness substantial growth during the forecast period, growing adoption of advanced insulin therapies, continuous advancements in cell and regenerative medicine, and the development of disease-modifying therapies. The emergence of innovative therapies such … Continue reading →